Siegfried Holding
Siegfried Holding AG, commonly referred to as Siegfried, is a prominent player in the pharmaceutical and chemical industry, headquartered in Switzerland (CH). Founded in 1873, the company has established a strong presence in Europe and North America, focusing on the development and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. Siegfried is renowned for its innovative solutions in contract development and manufacturing, catering to a diverse clientele in the pharmaceutical sector. The company’s commitment to quality and sustainability sets it apart, ensuring compliance with stringent regulatory standards. With a robust market position, Siegfried has achieved significant milestones, including strategic acquisitions that have expanded its capabilities and global reach. As a trusted partner in the pharmaceutical supply chain, Siegfried continues to drive advancements in drug development and production.
DitchCarbon Score
How does Siegfried Holding's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Siegfried Holding's score of 41 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Siegfried Holding's reported carbon emissions
In 2023, Siegfried Holding AG reported total carbon emissions of approximately 68,166,000 kg CO2e, comprising 57,688,000 kg CO2e from Scope 1 and 10,478,000 kg CO2e from Scope 2. Additionally, their Scope 3 emissions were significant, amounting to about 459,700,000 kg CO2e, which includes categories such as purchased goods and services, employee commute, and waste generated in operations. Siegfried has set ambitious climate commitments, aiming for a 50% reduction in Scope 1 and Scope 2 emissions by 2030, using 2020 as the baseline year. This commitment reflects their focus on reducing their carbon footprint in the near term. Furthermore, the company has pledged to achieve net-zero emissions across all scopes by 2050, demonstrating a long-term commitment to sustainability. The company operates within the Pharmaceuticals, Biotechnology, and Life Sciences sector and is headquartered in Switzerland (CH). Their proactive approach to carbon management aligns with industry standards and reflects a growing trend among companies to address climate change through measurable targets and transparent reporting.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 16,300,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 00,000,000 | 0,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Siegfried Holding is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
